---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-033749"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2026-08-19T20:52:07+00:00"
generated_at: "2026-08-19T20:53:10.059445+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PDS Biotech CFO Lars Boesgaard resigns; interim CFO and PIO appointed

## Summary
- Lars Boesgaard resigns as CFO, PFO and PAO effective Sept 12, 2026, to pursue other professional endeavors.
- Resignation is not due to any disagreement with Company operations, policies or practices.
- Frank Bedu-Addo, Ph.D. (President & CEO) appointed interim Principal Financial Officer, effective Sept 12, 2026.
- Janetta Trochimiuk (Controller) appointed interim Principal Accounting Officer; salary $279,519.57/yr, no new equity awards.
- Trochimiuk has 25+ years as Controller/CFO; prior Controller at Delcath Systems and other firms.

## SEC filing metadata
- accession: 0001140361-26-033749
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2026-08-19T20:52:07+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/ef20080681_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-033749
- JSON: https://secwatch.observer/filing/0001140361-26-033749.json
- Plain text: https://secwatch.observer/filing/0001140361-26-033749.txt

## Key facts
- Executive change
  Janetta Trochimiuk was appointed as Principal Accounting Officer at PDS Biotechnology Corp.
  - Action: appointed
  - Role: Principal Accounting Officer
  source text: On August 19, 2026, the board of directors of the Company appointed Janetta Trochimiuk, the Company’s Controller, as interim Principal Accounting Officer and Frank Bedu-Addo, Ph.D., the Company’s President and Chief Executive Officer, as interim Principal Financial Officer, each effective as of September 12, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm
- Executive change
  Frank Bedu-Addo was appointed as Principal Financial Officer at PDS Biotechnology Corp.
  - Action: appointed
  - Role: Principal Financial Officer
  source text: On August 19, 2026, the board of directors of the Company appointed Janetta Trochimiuk, the Company’s Controller, as interim Principal Accounting Officer and Frank Bedu-Addo, Ph.D., the Company’s President and Chief Executive Officer, as interim Principal Financial Officer, each effective as of September 12, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm
- Executive change
  Lars Boesgaard resigned as Chief Financial Officer at PDS Biotechnology Corp.
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On August 13, 2026, Lars Boesgaard submitted his resignation, effective as of September 12, 2026, as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of PDS Biotechnology Corporation (the “ Company ”) in order to pursue other professional endeavors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.